Cannabis Bioscience International Holdings

CBIH · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0002

About CBIH

Cannabis Bioscience International Holdings, Inc. engages in the provision of services in therapeutic areas of clinical research. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2009-09-25. The firm provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. The company offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.

Employees
2
Headquarters
Houston, Texas
Listed
Sep 25, 2009
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
cbih.net

Leadership

Cannabis Bioscience International Holdings executives
NameTitleSince
Dante Picazo—2019
John Jones—2020
Jose Torres—2019
Charles Tamburello——

Similar companies

Companies in the same industry as Cannabis Bioscience International Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.